Comparability of GFAP and UCH-L1 Measurements Using Handheld and Core Laboratory TBI Plasma Tests and Their Diagnostic Performance for Traumatic Intracranial Lesions
The Journal of Applied Laboratory Medicine · 04.11.2026 · 11 (6) · 1364-1377
DOI: 10.1093/jalm/jfag093 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift The Journal of Applied Laboratory Medicine, online erschienen am 10.09.2026. Verfasst von Nathan B Roberts und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, University of Michigan, Ann Arbor, MI, United States. Hauptthemen laut MEDLINE: Glial Fibrillary Acidic Protein, Ubiquitin Thiolesterase, Brain Injuries, Traumatic. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Abbott Laboratories, Congressionally Directed Medical Research Programs, United States Department of Defense.
Abstract (Originalsprache)
Background
Glial fibrillary acidic protein (GFAP) and ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) are cleared by the U.S. Food and Drug Administration (FDA) to aid computed tomography (CT) decision-making in patients with traumatic brain injury (TBI). Two commercial assays, i-STAT TBI Plasma test and Alinity i TBI test, quantify these biomarkers using distinct detection technologies. Limited comparative data exist, creating uncertainty about cross-platform agreement and interchangeability of results in clinical and research applications.
Methods
GFAP and UCH-L1 concentrations were measured twice from 829 adults who underwent brain CT within 24 h of blunt trauma, first using the Abbott i-STAT TBI Plasma test and second using the Alinity i TBI test. Agreement was assessed using percent agreement (binary outcomes), Bland–Altman plots, Passing–Bablok regression, and Pearson correlation, with and without imputed values for out-of-range results. Diagnostic accuracy for traumatic intracranial lesions (tICLs) was calculated at assay-specific cutoffs.
Results
For GFAP + UCH-L1 in combination, the overall cross-platform agreement was 92.28%. GFAP and UCH-L1 showed strong cross-platform correlations with imputed (r = 0.916 and 0.916, respectively) and non-imputed data (r = 0.942 and 0.909, respectively). Both tests detected all clinically significant tICLs, with sensitivities of 100% (95% CI, 89%–100%) and negative predictive value (NPV) of 100% (95% CI, 98%–100%). Specificities were 29% (95% CI, 26%–32%) for i-STAT and 25% (95% CI, 22%–28%) for Alinity i.
Conclusions
GFAP and UCH-L1 showed strong cross-platform agreement, individually and in combination, with equivalent sensitivity for tICL, supporting clinical interchangeability of the binary positive/negative test results.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Emergency Medicine, University of Michigan, Ann Arbor, MI, United States.
- Department of Emergency Medicine, Medical University of South Carolina, Charleston, SC, United States.
- Department of Pathology, University of Michigan, Ann Arbor, MI, United States.
- Department of Biostatistics, University of Michigan, Ann Arbor, MI, United States.
- Industrial and Operations Engineering Department, University of Michigan, Ann Arbor, MI, United States.
- Department of Radiology, University of Michigan, Ann Arbor, MI, United States.
ORCID-Profile: Carmen Gherasim, Frederick K Korley
Förderung
- Abbott Laboratories
- Congressionally Directed Medical Research Programs
- United States Department of Defense
Zitieren
APA
Roberts, N. B., Gherasim, C., Li, K., Xie, T., Falk, H., Bapuraj, J., Demski, D., Fung, C. M., Haas, N. L., Kocher, K. E., Seagly, K. S., Medlin, R. P., Joseph, J., Schipper, M. J., Chandran, R., Marino, J. A., McQuiston, B., Pradhan-Bhatt, S., & Korley, F. K. (2026). Comparability of GFAP and UCH-L1 Measurements Using Handheld and Core Laboratory TBI Plasma Tests and Their Diagnostic Performance for Traumatic Intracranial Lesions. The Journal of Applied Laboratory Medicine, 11(6), 1364-1377. https://doi.org/10.1093/jalm/jfag093
Vancouver
Roberts NB, Gherasim C, Li K, Xie T, Falk H, Bapuraj J, et al. Comparability of GFAP and UCH-L1 Measurements Using Handheld and Core Laboratory TBI Plasma Tests and Their Diagnostic Performance for Traumatic Intracranial Lesions. The Journal of Applied Laboratory Medicine. 2026;11(6):1364-1377. doi:10.1093/jalm/jfag093
BibTeX
@article{Roberts2026,
author = {Roberts, Nathan B and Gherasim, Carmen and Li, Kexin and Xie, Tian and Falk, Hayley and Bapuraj, Jayapalli and Demski, Debra and Fung, Christopher M and Haas, Nathan L and Kocher, Keith E and Seagly, Katharine S and Medlin, Richard P and Joseph, Jacob and Schipper, Matthew J and Chandran, Raj and Marino, Jaime A and McQuiston, Beth and Pradhan-Bhatt, Swati and Korley, Frederick K},
title = {Comparability of GFAP and UCH-L1 Measurements Using Handheld and Core Laboratory TBI Plasma Tests and Their Diagnostic Performance for Traumatic Intracranial Lesions},
journal = {The Journal of Applied Laboratory Medicine},
year = {2026},
volume = {11},
number = {6},
pages = {1364--1377},
doi = {10.1093/jalm/jfag093}
}
EUVIMED